Literature DB >> 30022919

Abdominoperineal Resection for Unexpected Distal Intramural Spreading of Rectal Cancer.

Shinya Munakata1, Yuta Murai1, Akihiro Koizumi1, Hisaki Kato1, Riku Yamamoto1, Syuhei Ueda1, Satoshi Tokuda1, Syunsuke Sakuraba1, Tomoyuki Kushida1, Hajime Orita1, Mutsumi Sakurada1, Hiroshi Maekawa1, Koichi Sato1, Ryo Wada2.   

Abstract

INTRODUCTION: In rectal cancer, distal intramural spread may sometimes occur, but a maximum extent of distal spread of > 6 cm is very rare. CASE
PRESENTATION: A 65-year-old Japanese male with an advanced rectal cancer tumor with para-aortic lymph node metastasis was admitted. We performed a low anterior resection with lymphadenectomy, but the intraoperative frozen-section analysis of margins revealed malignant cell positivity; we, therefore, performed an abdominoperineal resection. Pathological findings showed that the maximum extent of distal spread was 6 cm. After 12 courses of FOLFOX4 as adjuvant chemotherapy, abdominal computed tomography revealed whole lymph node metastases, including Virchow's node. Though FOLFIRI + panitumumab was started, he was not eligible for additional chemotherapy after 10 cycles.
CONCLUSION: An intraoperative frozen pathology examination was helpful for the additional resection, when unexpected distal spreading had occurred in rectal cancer. The evidence of a distal negative margin should not be underestimated.

Entities:  

Keywords:  Abdominoperineal resection; Distal intramural spread; Rectal cancer

Year:  2018        PMID: 30022919      PMCID: PMC6047569          DOI: 10.1159/000490043

Source DB:  PubMed          Journal:  Case Rep Gastroenterol        ISSN: 1662-0631


Introduction

The existence of microscopic tumor implants in the intestinal wall, distal to the inferior edge of a macroscopic tumor (either continuous or discontinuous with the tumor), is called distal intramural spread (DIS) [1]. In their study of 381 cases, Shimada et al. [2] reported that distal spread was detected in 14.7%, DIS only in 6.6%, mesorectal distal spread only in 4.5%, and both intramural and mesorectal distal spread in 3.7%. The most common category of DIS was direct invasion, and the most common category of mesorectal distal spread was extranodal cancer tissue [2]. Using a definition of “long distal spread” of ≥2 cm in rectal cancer [3], only 2.1% of their patients had long distal spread [2]. The maximum extent of distal spread was 24–50 mm as extranodal cancer tissue, deposit, and nodal involvement [2, 4, 5]. Here, we report a rare case of a 6-cm maximum extent of DIS diagnosed pathologically.

Case Presentation

A 65-year-old Japanese man was admitted to our hospital for the treatment of a rectal tumor incidentally found by colonoscopy during a routine medical checkup. No apparent abnormalities were found on physical examination at admission, and the patient had no prior history of malignancy. A colonoscopy demonstrated a type 3, 7-cm-diameter rectal cancer located 10 cm proximal to the anal verge plus 2-cm DIS that had occurred due to lymphatic permeation (Fig. 1a). The colonoscopic biopsy from the tumor revealed a moderately differentiated adenocarcinoma. The dilatation was further assessed with a barium enema examination, which demonstrated an apple core sign at the rectum that was causing a mild obstruction (Fig. 1b). The upper gastrointestinal endoscopic findings were unremarkable.
Fig. 1

a The endoscopy demonstrated a rectal cancer and distal spreading with mucosal edema. b A barium enema examination which demonstrated an apple core sign at the rectum that was causing a mild obstruction. c The computed tomography showed advanced rectal cancer and para-aortic lymph node metastasis.

Computed tomography (CT) of the patient's chest and abdomen demonstrated no evidence of metastasis in distant organs; however, swelling of the lymph nodes around the rectum and of the para-aortic lymph node was observed (Fig. 1c). The level of carcinoembryonic antigen was 3 ng/mL, and that of cancer antigen 19-9 was 6 ng/mL. Other laboratory results were normal. To determine whether sphincter-preserving surgery could be possible, we planned to perform a low anterior resection with lymphadenectomy, including the para-aortic lymph node with a 5-cm margin including the 2-cm DIS. However, an intraoperative frozen-section analysis of margins revealed positivity for malignant cells, and we therefore performed an abdominoperineal resection (APR). The operation time was 7 h and 12 min, and the blood loss was 660 mg. A gross examination of the resected specimen showed a Borrmann type 3 lesion (ulcerofungating type) (5 × 4 cm) in the rectum (Fig. 2a). The final pathological stage was T4a N2b M1b (para-aortic lymph node) (stage 4B according to the Union for International Cancer Control). The patient had no postoperative complications and was discharged on postoperative day 16.
Fig. 2

a The macroscopic view of the surgically resected specimen shows a 5 × 4 cm cancer at the rectum. b Microscopic examination of the resected specimen. Morphology on routine staining (HE, ×40) at the end of the margin showed that the tumor cells were spreading over 6 cm from the edge of the main tumor.

Adjuvant chemotherapy with FOLFOX (5-fluorouracil, leucovorin, oxaliplatin) was administered to the patient for 6 months on an outpatient basis. At the end of this treatment, the patient underwent a restaging CT scan, which showed progressive disease with Virchow's lymph node metastasis. We initiated treatment with FOLFIRI (5-fluorouracil, leucovorin, irinotecan) + panitumumab. The patient was not eligible for additional chemotherapy after 10 cycles. However, he is now well 24 months after his surgery.

Discussion

There are many reports of DIS in the rectum, but a maximum extent of distal spread > 6 cm is very rare. Williams et al. [6] reported that among 50 patients with rectal cancer, the size of the DIS was < 1 cm in 78.4%, > 2 cm in 6%, and > 3 cm in only 1.6%. Shimada et al. [2] observed similar values. Moreover, distal spread easily develops in patients with stage III or IV disease compared to those with stage I or II disease [2, 7]. Though ultrasonography has been recommended for the detection of DIS [8], we could not examine the ultrasonography findings in the present patient. Regarding the preoperative diagnosis of DIS, it is generally difficult to detect a DIS lesion before surgery. In our patient's case, there was apparently a DIS lesion in epithelial change as shown by endoscopy. However, the length of the DIS as diagnosed by endoscopy was quite different from what we expected. Shimada et al. [2] noted a long distal spread of rectal cancer in the mesorectum detected with whole-mount sections. The DIS in our patient's case was 6 cm. Obtaining a negative distal resection margin remains an important goal in rectal cancer resection. A distal margin of ≥2 cm is recommended during sphincter-preserving surgery for rectal carcinoma [9]. In agreement with this recommendation, we performed a low anterior resection for our patient, but an APR had to be performed for a negative distal resection. We were compelled to perform the APR based on the frozen-section findings, which suggested remaining cancer cells. Frozen sectioning is a reliable method for determining an intraoperative free distal margin. Shirouzu et al. [7] showed that patients with noncurative and distal spread of rectal cancer have an extremely low survival rate and a high risk of distant metastasis rather than local recurrence. Considering our patient's case, it is clear that in cases of advanced rectal cancer we should not underestimate the distal margin and investigate the intraoperative frozen sections. Regarding para-aortic lymph node dissection (PALND), the reported incidence of isolated PALND ranges from 1.3 to 1.7% [10]. PALND was shown to confer a survival advantage in comparison with conventional palliative chemotherapy and with chemoradiation therapy [10]. Because our patient also had a distant lymph node metastasis, we performed the primary resection and PALND. We thus speculate that our management helped this patient be well for over 24 months. In conclusion, we have reported a case of rectal cancer with distal spreading > 6 cm. The evidence of a distal negative margin should not be underestimated.

Statement of Ethics

Written informed consent was obtained from the patient for publication of this case report and any accompanying images.

Disclosure Statement

The authors declare no conflicts of interest.

Author Contributions

Data acquisition: S.M., Y.M., A.K., H.K., R.Y., S.U., S.T., S.S., T.K., H.O., M.S., H.M. Drafting of the manuscript: S.M. Critical revision of the manuscript: K.S.
  10 in total

1.  Discontinuous rectal cancer spread in the mesorectum and the optimal distal clearance margin in situ.

Authors:  Chihiro Ono; Keigo Yoshinaga; Masayuki Enomoto; Kenichi Sugihara
Journal:  Dis Colon Rectum       Date:  2002-06       Impact factor: 4.585

2.  Intramural and mesorectal distal spread detected by whole-mount sections in the determination of optimal distal resection margin in patients undergoing surgery for rectosigmoid or rectal cancer without preoperative therapy.

Authors:  Yoshifumi Shimada; Yasumasa Takii; Satoshi Maruyama; Tamaki Ohta
Journal:  Dis Colon Rectum       Date:  2011-12       Impact factor: 4.585

3.  Preoperative detection of distal intramural spread of lower rectal carcinoma using transrectal ultrasonography.

Authors:  H Yanagi; M Kusunoki; Y Shoji; T Yamamura; J Utsunomiya
Journal:  Dis Colon Rectum       Date:  1996-11       Impact factor: 4.585

4.  [Distal intramural spread of adenocarcinoma of the rectum after neoadjuvant therapy].

Authors:  C Ignacio Raffa; Lilia Schmitz; Sebastián Fandiño; Pablo J Sánchez; Eduardo Bumaschny
Journal:  Acta Gastroenterol Latinoam       Date:  2014

5.  Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery.

Authors:  K Shirouzu; H Isomoto; T Kakegawa
Journal:  Cancer       Date:  1995-08-01       Impact factor: 6.860

Review 6.  Adequate length of the distal resection margin in rectal cancer: from the oncological point of view.

Authors:  In Ja Park; Jin Cheon Kim
Journal:  J Gastrointest Surg       Date:  2010-02-09       Impact factor: 3.452

7.  Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients' survival.

Authors:  N S Williams; M F Dixon; D Johnston
Journal:  Br J Surg       Date:  1983-03       Impact factor: 6.939

8.  Pathological evidence in support of total mesorectal excision in the management of rectal cancer.

Authors:  J V Reynolds; W P Joyce; J Dolan; K Sheahan; J M Hyland
Journal:  Br J Surg       Date:  1996-08       Impact factor: 6.939

Review 9.  Management of para-aortic lymph node metastasis in colorectal patients: A systemic review.

Authors:  J S M Wong; G H C Tan; M C C Teo
Journal:  Surg Oncol       Date:  2016-10-03       Impact factor: 3.279

10.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer.

Authors:  Toshiaki Watanabe; Michio Itabashi; Yasuhiro Shimada; Shinji Tanaka; Yoshinori Ito; Yoichi Ajioka; Tetsuya Hamaguchi; Ichinosuke Hyodo; Masahiro Igarashi; Hideyuki Ishida; Soichiro Ishihara; Megumi Ishiguro; Yukihide Kanemitsu; Norihiro Kokudo; Kei Muro; Atsushi Ochiai; Masahiko Oguchi; Yasuo Ohkura; Yutaka Saito; Yoshiharu Sakai; Hideki Ueno; Takayuki Yoshino; Narikazu Boku; Takahiro Fujimori; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Keiichi Takahashi; Osamu Tsuruta; Toshiharu Yamaguchi; Masahiro Yoshida; Naohiko Yamaguchi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2015-03-18       Impact factor: 3.402

  10 in total
  2 in total

1.  Rectal cancer with extensive distal intramural spread treated by abdominoperineal resection.

Authors:  Harunobu Sato; Miho Shiota; Asako Okabe; Tetsuya Tsukamoto; Katsuyuki Honda; Zenichi Morise; Ichiro Uyama
Journal:  Int Cancer Conf J       Date:  2019-08-07

2.  Intramural cancer recurrence in the rectum after curative surgery for proximal sigmoid colon cancer: a case report.

Authors:  Yusuke Asada; Katsuya Chinen; Ken Yamataka; Jo Tokuyama; Naoto Kurihara; Shuhei Iida
Journal:  World J Surg Oncol       Date:  2022-10-03       Impact factor: 3.253

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.